Market Overview

rHEALTH Technology Awarded in NASA's Civilian Commercialization Readiness Pilot Program (CCRPP)

Share:

rHEALTH Technology Awarded in NASA's Civilian Commercialization Readiness Pilot Program (CCRPP)

PR Newswire

CAMBRIDGE, Mass., Aug. 20, 2018 /PRNewswire-iReach/ -- DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, a digital health solutions company, today announced that the rHEALTH technology is a subject of NASA's Civilian Commercial Readiness Pilot Program (CCRPP). Recipients of CCRPP awards must not only demonstrate maturation of technology that aligns with NASA interests, but also strong potential use in markets outside of NASA. This competitive award comes after successful completion of Phase I and Phase II of Small Business Innovation Research (SBIR) and Small Technology Transfer (STTR) Programs.

"We are honored and thrilled to continue our collaboration with NASA to deliver a flight-ready prototype of our unique diagnostic and monitoring technology to the International Space Station," stated Dr. Eugene Chan, President and CEO.

The main project goal is enabling point-of-patient care in space medicine through delivering portable wireless health solutions—including the rHEALTH small volume blood analyzer and the SKYE Sensor vitals monitor—to astronauts working in the International Space Station.

About rHEALTH

rHEALTH is an innovative digitial health solutions company focused on creating integrated technologies that fundamentally change how we care for our health. rHEALTH's innovations consists of the rHEALTH diagnostic platform, which enables diverse laboratory test classes in a single small volume blood sample intended as a point-of-care solution, the SKYE Sensor, a wireless wearable providing comprehensive real-time vitals monitoring and CHAS, a user-friendly mobile application. For more information, visit www.rhealth.com

About DNA Medicine Institute

DNA Medicine Institute (DMI) is a biomedical incubator focused on advancing patient care, alleviating human suffering, and treating disease through innovation. Its work is supported by NASA, National Institutes of Health, and the Bill & Melinda Gates Foundation. DMI leverages substantial expertise in interdisciplinary science and engineering to solve challenging problems. For more information, visit www.dnamedinstitute.com.  

Media Contact: Lillian Li, DNA Medicine Institute (DMI), rHEALTH, (617) 913-7630, pr@rhealth.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE rHEALTH LLC

View Comments and Join the Discussion!